1111 - Functional analysis of in-frame variants in TP53 gene identified in adult leukemias: A study of the TP53 Network of European Research Initiative on CLL

Primary Author / Presenter(s)

SP

Sarka Pavlova, PhD

senior scientist
1. Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic and 2. Central European Institute of Technology (CEITEC), Masaryk University,
Brno, Czech Republic

Co-Author(s)

JG

Johana Gombíková

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic
Brno, Jihomoravsky kraj, Czech Republic
SP

Silvia Petrezsélyová, MSc

Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences
Prague, Hlavni mesto Praha, Czech Republic
LM

Libor Macůrek, PhD

Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences
Prague, Hlavni mesto Praha, Czech Republic
MZ

Marcela Zenatova, MSc

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University
Brno, Czech Republic
MZ

Marie Zádrapová

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic
Brno, Jihomoravsky kraj, Czech Republic
BF

Blanca Ferrer-Lores, MD

Department of Hematology, Hospital Clínico Universitario-INCLIVA
Valencia, Comunidad Valenciana, Spain
AS

Alicia Serrano Alcala

INCLIVA Biomedical Research Institute, Valencia 46010, Spain.
Valencia, Comunidad Valenciana, Spain
Eugen Tausch, MD

Treating Physician and Research Fellow
Division of CLL, Department of Internal Medicine III, University Hospital Ulm
Ulm, Germany
Stephan Stilgenbauer, MD

Professor of Medicine, Medical Director
Division of CLL, Internal Medicine III, Ulm University
Ulm, Baden-Wurttemberg, Germany
FB

Fanny Baran-Marszak, MD

GHUPSSD Hôpital Avicenne AP-HP, INSERM U978 Université Sorbonne Paris Nord, Bobigny, France
Paris, Ile-de-France, France
GL

Gregory Lazarian, PhD

GHUPSSD Hôpital Avicenne AP-HP, INSERM U978 Université Sorbonne Paris Nord
Bobigny, France
EZ

Eva Zapletalová, PhD

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic
Brno, Jihomoravsky kraj, Czech Republic
JK

Jana Kopecna, MSc

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic
Brno, Jihomoravsky kraj, Czech Republic
MA

Miguel Alcoceba, PhD

Head of Department
Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)
Salamanca, Castilla y Leon, Spain
AB

Ana Balanzategui

Laboratory technician
Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)
Salamanca, Castilla y Leon, Spain
LB

Lisa Bonello

Molecular Pathology Unit, AOU Citta` della Salute e della Scienza, Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy
Torino, Piemonte, Italy
IJ

Ivana Ježíšková

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic
Brno, Jihomoravsky kraj, Czech Republic
IH

Imrich Hikkel

Department of Medical Genetics, National Cancer Institute, Bratislava, Slovakia
Bratislava, Bratislava, Slovakia
MS

Martina Sopkovičová

Department of Medical Genetics, National Cancer InstituteBratislava, Slovakia
Bratislava, Bratislava, Slovakia
SZ

Silvia Zibellini

Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia
Pavia, Lombardia, Italy
MV

Marzia Varettoni, MD

Divisione di Ematologia, Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardia, Italy
AB

Audrey Bidet

Laboratoire d’Hématologie Biologique, CHU Bordeaux, Bordeaux, France
Bordeaux, Aquitaine, France
HP

Helena Podgornik

University medical center, Ljubljana; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
Ljubljana, Ljubljana, Slovenia
SS

Sandra Sucurovic

University medical center, Ljubljana, Slovenia
Ljubljana, Ljubljana, Slovenia
Riccardo Moia, MD, PhD

Postdoctoral Fellow
Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara
Novara, Piemonte, Italy
ML

Monica Lopez-Guerra, PhD

Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS); Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
Barcelona, Spain
MC

Mark Catherwood, PhD

Haematology Department, Belfast City Hospital
Belfast, Northern Ireland, United Kingdom
�P

Šárka Pospíšilová, PhD

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Central European Institute of Technology, Masaryk University
Brno, Jihomoravsky kraj, Czech Republic
JM

Jitka Malcikova, PhD

1. Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic and 2. Central European Institute of Technology (CEITEC), Masaryk University
Brno, Czech Republic